FAS and primary cutaneous T-cell non-Hodgkin lymphoma: Although CTCL cells repress the expression of FAS, it could be epigenetically increased via the de-repression of the FAS promoter by DNA hypomethylation, which can enhance tumor cell apoptosis in patients with CTCL [38].